Fifty-four cases of peripheral nerve sheath tumours within the orbit are reviewed.
The majority of peripheral nerve sheath tumours comprise benign neurofibromas or neurilemmomas and malignant nerve sheath tumours are relatively rare.
In the absence of systemic neurofibromato sis, peripheral nerve sheath tumours are uncommon throughout the body and form only about 2-4% of orbital neoplasms.1-3 Orbital peripheral nerve sheath tumours have been reported in several small series and as solitary case-reports, some with unusual fea tures-for example, intramuscular location of a tumour,4 multiple tumours in a single orbit5-7 or malignant tumours.H. [8] [9] [10] [11] The clinical features and management of 54 peripheral nerve sheath tumours of the orbit are reviewed in this paper: Plexiform neu rofibromas are excluded from this report, being a group of diffuse tumours with distinc tive presentation and behaviour.
Patients and Methods
Fifty-four patients with isolated orbital peri pheral nerve sheath tumours were seen between 1969 and 1989, less than 2% of about 3,500 patients seen in the Orbital clinic.
A detailed clinical history was taken from each patient, with particular attention being directed to a personal or family history of neurological or dermatological abnormali ties. All patients had complete ophthalmic' evaluation and also assessment by a neurol ogist, for the systemic stigmata of neurofibro matosis (using criteria of Crowe and others). 12 Radiological investigation generally included plain orbital radiographs, computer� ised orbital tomography (after 1974) and orbi tal venography (before 1974). Orbital B-mode ultrasound investigation was used only rarely.
Results are compared by analysis of vari· ance, the 'Student' t statistic and the Chi squared statistic.
Results
The sex incidence and the ages at presentation are similar in three diagnostic groups (Table I ; Fig. 1) .
The presenting symptoms for neurofibro mas, neurilemmomas and malignant nerve sheath tumours are similar (Table I) . How ever, the duration of first symptom at presen tation is significantly greater for neurofibromas than for neurilemmomas (P<0.05), but that for benign neurilemmo mas and malignant nerve sheath tumours are similar (P<0.9). The clinical signs for benign and malignant nerve sheath tumours are almost exclusively those of an orbital mass: Thus, about 75% of the benign tumours caused non-axial dis placement of the globe and over 90% caused proptosis (from 1-12 mm). An anterior orbi tal mass was palpable and eye movements were restricted in about two-thirds of patients. Visual function was reduced in 9/50 (18%) cases, some with choroidal striae (six cases), papilloedema (three cases) or optic atrophy (two cases). There was a detectable trigeminal sensory loss in 6/50 (12%) of the benign, in contrast to 2/4 (50%) of the malig nant, nerve sheath tumours .
Benign nerve sheath tumours typically have a smooth contour on CT scanning ( Fig. 2 ) and expand neighbouring orbital walls (25/30 cases; Fig. 3 ). Extension to the superior orbi tal fissure (Fig. 4) was evident in 11/27 (41 %) scans. However, flattening of the globe was unusual (5128 scans) and tumour calcification was not evident in any of the scans (at soft tissue settings). The intraorbital distribution of neurofibromas and neurilemmomas, as determined radiologically or surgically (Fig . Fig. 2 . Axial CT scan demonstrating a smo{)thly contoured benign neurilemmoma in the intraconal space, displacing the optic nerve medially.
5), shows a significant departure from random: Lesions are superiorly-located sig nificantly more often than inferiorly in most spaces within the orbit (P<O.OOl; Fig. 5 ). Similarly, posteriorly (P<O.05) and in the middle one-third intraconally (P<O.01), lat erally-located tumours are more common than medial. The nerve(s) of origin for neu rofibromas is more readily identifiable than that for neurilemmomas (Table II) .
Tumours were mainly resected through lat eral orbitotomy (Table II) , although complete resection was achieved with only 72% of neu rilemmomas and 46'/'0 of neurofibromas (P<O.05). Orbital neurofibromas extending intracranially, too extensive for resection, were present in two patients. double neuro fibromas in two others and multiple neuro fibromas in three patients.
Intraoperative complications were few and included minor leaks of cerebro-spinal fluid from the superior orbital fissure (one case) or orbital roof (one case) and damage to branches of the ophthalmic artery (two cases).
The postoperative results and complica tions are presented in Table III . 
Discussion
Benign peripheral nerve sheath tumours com prise a variable proliferation and mixture of axons, Schwann cells, supporting endoneural cells and vascular elements.I-J Neurilemmo mas (Schwannomas) are generally well defined. often eccentric from the nerve of ori gin, and show a predominance of spindle-shaped Schwann cells; these latter cells often displaying palisading of nuclei (Antoni A pattern) or a less organised pattern (Antoni B). Axons are infrequent within, and often pass eccentrically through, the main mass of a neurilemmoma. Neurofibromas more commonly arise within nerves and dis play more endoneural proliferation, thus expanding and forming an intimate relation to the parent nerve. When there is multiple involvement of adjacent nerve branches, the effect is to produce a composite mass of thick ened nerve bundles and, as such. the tumours are usually referred to as 'plexiform'. Neu rofibromas and, to a lesser degree, neurilem momas can undergo degeneration, manifest as myxoid or cystic change and haemorrhage; inflammatory cell infiltration may occur with this degeneration. Malignant nerve sheath tumours are infrequent.
11

Epidemiology and Presentation
Orbital neurilemmomas and neurofibromas comprised less than 2% of patients seen in the Orbital clinic at Moorfields Eye Hospital and about 5°;; , of the orbital tumours; this latter figure being somewhat higher than other smaller studies. I. 3 The sex incidence and age distributions (Table I) agree with those for other series. H The equal incidence of neu rofibromas and neurilemmomas is, however, Patients with benign orbital neurofibromas and neurilemmomas generally give a long history of progressive symptoms due to the orbital mass; the duration of symptoms is sig nificantly longer with neurofibromas (Table  I) , although the reason for this is unclear. Although Rootman3 suggests changes of sen sory nerve function to be 'frequently noted' with neurofibromas, in the present series dis turbance of trigeminal nerve function is uncommon with benign tumours and appears to occur more frequently with malignancy. Seven of the 25 patients (28%) with orbital neurofibromas had a family history and/or systemic signs of neurofibromatosis, in con trast to none of the 25 patients with neurilem momas (P<O.01).
Clinical and radiological signs for nerve sheath tumours, benign or malignant, are typically those of a slowly-expanding orbital massl3 and only few signs-such as trigeminal sensory loss or destruction of bone11-tend to favour malignancy.
Benign nerve sheath tumours occurred sig nificantly more often in the upper half of the orbit (Fig. 5) , this probably being a mani festation of the greater number of sensory nerves in this location. The nerves of origin were evident for 63% of neurofibromas, 32% of benign neurilemmomas and 50% of malig nant nerve sheath tumours (Table II) . was possible through an anterior orbitotomy in one-third of cases, although lateral orbito tomy, transfrontal orbitotomy or exenteration was required to excise more extensive or pos terior lesions (Table II) . The benign nerve sheath tumours were found to extend into the superior orbital fissure in 28% of 47 cases, this limiting the extent of resection. Complete resection was significantly more frequent with neurilemmomas than neurofibromas (P<O.05), this reflecting the localised nature of many neurilemmomas.
Surgery for Benign Tumours and its
Because of the difficulty of surgical dissec tion near the apex of the orbit, there was a sig nificant, but low, incidence of surgical complications: Two patients developed minor leaks of cerebro-spinal fluid which ceased spontaneously and two other patients devel oped transient, but marked, neuropraxia of motor nerves-possibly due to peri-operative oedema at the superior orbital fissure.
In most cases, ocular motility and visual function improved after resection of bulky neurofibromas or neurilemmomas (Table  Ill) . In six (13%) patients visual function was reduced after surgery and ten (21 %) devel oped a fixed mydriasis, possibly due to impair ment of blood-flow to the optic nerve or ciliary ganglion. One patient developed cen tral retinal artery occlusion after resection of a neurofibroma situated intraconally within the posterior one-third of the orbit. Impairment of the function of extraocular muscles or leva tor palpebrae, often marked in the early post operative period, generally recoverd over several months; three patients needed further surgery for squint or ptosis.
Although resection of a sensory nerve sheath tumour would reasonably be expected to produce a sensory deficit, this was clinically detectable in only 32% of neurilemmomas and 72% of neurofibromas (Table III) . The lack of a clinically detectable deficit presum ably arising because these tumours originate on minor branches of sensory nerves, are sited eccentrically from the sensory nerve of origin, or arise on nerves not subserving cutaneOUIl sensorium (for example, autonomic nerves; perhaps the cause of some cases with post operative mydriasis).
Malignant Nerve Sheath Tumours
The similar duration of symptoms for benign neurilemmomas and malignant nerve sheath tumours (which, in this series, all displayed features of malignant neurilemmomas) would suggest that such malignant tumours are arising de novo and not through a malignant transformation within a preceding benign tumour.
Complete resection of malignant nerve sheath tumours was possible in only one of the four patients, the others undergoing diagnos tic biopsy or debulking of tumour mass.
Clinical Recurrence of Tumours after Surgical Resection
Even for patients in whom resection of benign nerve sheath tumours was known to be incom plete, there has been no evidence of recur rence or continued growth--even to 23 years of follow-up. It is possible that surgical debulking of such (benign) tumours alters the growth pattern, perhaps by removal of tumour growth factors.
One of the patients with malignant nerve sheath tumour died within four months of diagnosis and one patient was lost to fol low-up. Two patients are alive and disease free at one-and-a-half and eight years after resection of tumours of low-grade malignancy.
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